The protective effects of fenofibrate in diabetes-related susceptibility to ischaemia

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1066541

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Blood flow reduction (blockage of arteries) to local tissue is a common problem for diabetic people. Fenofibrate, a cholesterol lowering drug, dramatically reduces the diabetes-related limb amputation and other vascular disorders. We plan to study the mechanism of fenofibrate to facilitate growth of new blood vessels to sites affected by vascular disease. Ultimately, this may result in new treatment for diabetic vascular complications.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $630,571.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

angiogenesis | cardiovascular disease | diabetes | diabetic complications | ischaemia

Related Links